These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2199 related items for PubMed ID: 9045349
21. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). Burke MJ, Cao Q, Trotz B, Weigel B, Kumar A, Smith A, Verneris MR. Pediatr Blood Cancer; 2009 Dec 15; 53(7):1289-94. PubMed ID: 19731318 [Abstract] [Full Text] [Related]
22. The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Ringdén O, Labopin M, Gorin NC, Meloni G, Blaise D, Reiffers J, Carlson K, Fouillard L, Frassoni F. Bone Marrow Transplant; 2000 May 15; 25(10):1053-8. PubMed ID: 10828865 [Abstract] [Full Text] [Related]
23. High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7-year Italian multicentre study. Uderzo C, Rondelli R, Dini G, Dallorso S, Messina C, Miniero R, Locatelli F, De Manzini A, Pession A, Balduzzi A. Br J Haematol; 1995 Apr 15; 89(4):790-7. PubMed ID: 7772514 [Abstract] [Full Text] [Related]
24. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W. Haematologica; 2002 Jan 15; 87(1):52-8. PubMed ID: 11801465 [Abstract] [Full Text] [Related]
25. Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission. Singhal S, Henslee-Downey PJ, Powles R, Chiang KY, Godder K, Treleaven J, Kulkarni S, Van Rhee F, Sirohi B, Pinkerton CR, Meller S, Jovanovic B, Mehta J. Bone Marrow Transplant; 2003 May 15; 31(10):889-95. PubMed ID: 12748665 [Abstract] [Full Text] [Related]
28. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O. J Clin Oncol; 2004 Jul 15; 22(14):2816-25. PubMed ID: 15254049 [Abstract] [Full Text] [Related]
29. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA. N Engl J Med; 1994 Nov 10; 331(19):1253-8. PubMed ID: 7935682 [Abstract] [Full Text] [Related]
33. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma. Chen CI, Roitman D, Tsang R, Stewart AK, Keating A, Crump M. Bone Marrow Transplant; 2002 Dec 10; 30(12):885-91. PubMed ID: 12476281 [Abstract] [Full Text] [Related]
34. Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia Pediatrica. Messina C, Valsecchi MG, Aricò M, Locatelli F, Rossetti F, Rondelli R, Cesaro S, Uderzo C, Conter V, Pession A, Sotti G, Loiacono G, Santoro N, Miniero R, Dini G, Favre C, Meloni G, Testi AM, Werner B, Silvestri D, Arrighini A, Varotto S, Pillon M, Basso G, Zanesco L. Bone Marrow Transplant; 1998 Jan 10; 21(1):9-14. PubMed ID: 9486488 [Abstract] [Full Text] [Related]
35. Autologous or allogeneic bone marrow transplantation for acute myeloblastic leukemia in second complete remission. Importance of duration of first complete remission in final outcome. Tomás F, Gómez-García de Soria V, López-Lorenzo JL, Arranz R, Figuera A, Cámara R, Alegre A, Fernández-Rañada JM. Bone Marrow Transplant; 1996 Jun 10; 17(6):979-84. PubMed ID: 8807103 [Abstract] [Full Text] [Related]
36. Indications and role of allogeneic bone marrow transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission. Uderzo C. Haematologica; 2000 Nov 10; 85(11 Suppl):9-11. PubMed ID: 11268333 [Abstract] [Full Text] [Related]
38. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission]. Wang HH, Feng SZ, Wang M, Wei JL, Jiang EL, Zhang L, Huang Y, Zhou SY, Liu QG, Qiu LG, Han MZ, Yan WW. Zhonghua Xue Ye Xue Za Zhi; 2004 Jul 10; 25(7):389-92. PubMed ID: 15355688 [Abstract] [Full Text] [Related]